Infectious diseases (London, England)
-
There is an urgent need to reduce mortality of COVID-19. We examined if corticosteroids and tocilizumab reduce risk for death in patients with severe pneumonia caused by SARS-CoV-2. ⋯ Combined treatment with corticosteroids and tocilizumab reduced mortality with about 25% in patients with severe COVID-19 pneumonia. Corticosteroids alone also resulted in lower in-hospital mortality rate compared to patients receiving only antiviral and antibiotic treatment. Corticosteroids alone or combined with tocilizumab may be considered in patients with severe COVID-19 pneumonia.
-
Italy was the first Western country to be seriously affected by COVID-19, and the first to implement drastic measures, which successfully curtailed the first wave of the epidemic. ⋯ Our findings of the observed correlation between face mask use and disease dynamics lend further support to the importance of face masks in addition to lockdowns and other restrictions for the control of COVID-19.